Grant: Doctoral Research Award: Canada Graduate Scholarships
University of Toronto
$105,000.00
Measuring Right Ventricular Pulmonary Arterial Coupling to Improve Prediction of Right Ventricular Failure in Patients with Heart Failure Post Advanced Therapies
EF 2022-23
Résumé
When the heart cannot pump blood adequately, that is referred to as heart failure (HF). HF affects over 600,000 Canadians annually. Patients with HF experience shortness of breath, failure of other organs, need hospitalization, and can die. There are "advanced therapies" for select patients with HF (e.g., heart transplant). The heart actually has two main pumping chambers, the left ventricle (pumps blood to the body) and the right ventricle (RV, pumps blood through the lungs). The RV does not typically need to pump with much force because blood pressure of the lungs or pulmonary arteries (PA, blood vessels connecting the heart and lungs) is normally very low. If HF patients develop high blood pressure in the lungs, the RV may not be strong enough to pump blood forward through the PA, and the RV can be permanently damaged and fail, also known as RV failure. After advanced therapies, RV failure can still happen resulting in high risk of death even after heart transplant. Therefore, it is important to know how the RV is working to identify which HF patients are at risk of developing RV failure after advanced therapies. Our laboratory has enhanced methods to improve how we measure the function of the RV and the pressures in the PA with a test called right heart catheterization. We can alter the pressures in the PA and then measure the response of the RV, which is known as RV-PA coupling. This will tell us if the RV and PA are working effectively together to push blood to the lungs. The purpose of our research is to measure RV-PA coupling in these patients when they undergo a right heart catheterization. Our goal is to use the knowledge we gain from how the RV and PA are working together to better predict if RV failure will occur in these patients after they undergo "advanced therapies".
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
475621
Name
Karvasarski Elizabeth
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Doctoral Research Awards - B
Projecttitle
Measuring Right Ventricular Pulmonary Arterial Coupling to Improve Prediction of Right Ventricular Failure in Patients with Heart Failure Post Advanced Therapies
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Heart Failure; Hemodynamics; Right Heart Catheterization; Right Ventricle
Abstract
When the heart cannot pump blood adequately, that is referred to as heart failure (HF). HF affects over 600,000 Canadians annually. Patients with HF experience shortness of breath, failure of other organs, need hospitalization, and can die. There are "advanced therapies" for select patients with HF (e.g., heart transplant). The heart actually has two main pumping chambers, the left ventricle (pumps blood to the body) and the right ventricle (RV, pumps blood through the lungs). The RV does not typically need to pump with much force because blood pressure of the lungs or pulmonary arteries (PA, blood vessels connecting the heart and lungs) is normally very low. If HF patients develop high blood pressure in the lungs, the RV may not be strong enough to pump blood forward through the PA, and the RV can be permanently damaged and fail, also known as RV failure. After advanced therapies, RV failure can still happen resulting in high risk of death even after heart transplant. Therefore, it is important to know how the RV is working to identify which HF patients are at risk of developing RV failure after advanced therapies. Our laboratory has enhanced methods to improve how we measure the function of the RV and the pressures in the PA with a test called right heart catheterization. We can alter the pressures in the PA and then measure the response of the RV, which is known as RV-PA coupling. This will tell us if the RV and PA are working effectively together to push blood to the lungs. The purpose of our research is to measure RV-PA coupling in these patients when they undergo a right heart catheterization. Our goal is to use the knowledge we gain from how the RV and PA are working together to better predict if RV failure will occur in these patients after they undergo "advanced therapies".
Competitiondate
202211
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Karvasarski, Elizabeth
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~